Relapsing Neuromyelitis Optica: Demographic and clinical features in Iranian patients

European Journal of Neurology

Volumn 17, Issue 6, 2010, Pages 794-799

  Sahraian, M A ^a,b   Moinfar, Z ^b   Khorramnia, S ^b   Mohammad Ebrahim, M ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Iran; Multiple sclerosis; Neuromyelitis Optica

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENT; INTERFERON; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; AQUAPORIN 4; AUTOANTIBODY; AUTOANTIGEN;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMOGRAPHY; DISEASE COURSE; DISEASE DURATION; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EXPANDED DISABILITY STATUS SCALE; FEMALE; HUMAN; IRAN; LOW DRUG DOSE; MALE; MYELITIS; MYELOOPTIC NEUROPATHY; NEUROLOGIC DISEASE; OPTIC NEURITIS; PRIORITY JOURNAL; RELAPSE; SCHOOL CHILD; SEX RATIO; SIDE EFFECT; SYMPTOM; TREATMENT DURATION; AGE; BLOOD; BRAIN; IMMUNOLOGY; NEUROMYELITIS OPTICA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PATHOPHYSIOLOGY; RECURRENT DISEASE; SPINAL CORD;

AGE FACTORS; AQUAPORIN 4; AUTOANTIBODIES; AUTOANTIGENS; BRAIN; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSIVE AGENTS; IRAN; MAGNETIC RESONANCE IMAGING; MALE; NEUROMYELITIS OPTICA; RECURRENCE; SPINAL CORD;

EID: 77952512759     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2009.02928.x     Document Type: Article

References (30)

1. Correale J, Fiol M. Activation of humoral immunity and eosinophils in Neuromyelitis Optica. Neurology 2004 63 : 2363 2370. (Pubitemid 40024351)
2. Wingerchuk DM, Hogancamp WF, O'Brien PC, Weinshenker BG. The clinical course of Neuromyelitis Optica (Devic's syndrome). Neurology 1999 53 : 1107 1114.
3. Shibasaki H, McDonald WI, Kuroiwa Y. Racial modification of clinical picture of multiple sclerosis: comparison between British and Japanese patients. J Neurol Sci 1981 49 : 253 271. (Pubitemid 11183868)
4. Lucchinetti CF, Mandler RN, McGavern D, et al. A role for humoral mechanisms in the pathogenesis of Devic's Neuromyelitis Optica. Brain 2002 125 : 1450 1461. (Pubitemid 34755161)
5. Papais-Alvarenga RM, Miranda-Santos CM, Puccioni-Sohler M, et al. Optic neuromyelitis syndrome in Brazilian patients. J Neurol Neurosurg Psychiatry 2002 73 : 429 435.
6. Wingerchuk DM, Lennon VA, Lucchinetti CF, Pittock SJ, Weinshenker BG. The spectrum of Neuromyelitis Optica. Lancet Neurol 2007 6 : 805 815.
7. de Sezea J, Stojkovic T, Ferriby D, et al. Devic's Neuromyelitis Optica: clinical, laboratory, MRI and outcome profile. J Neurol Sci 2002 197 : 57 61. (Pubitemid 34462145)
8. Fukazawa T, Yamasaki K, Ito H, et al. Both the HLA-DPB1 and -DRB1 alleles correlate with risk for multiple sclerosis in Japanese: clinical phenotypes and gender as important factors. Tissue Antigens 2000 55 : 199 205. (Pubitemid 30150939)
9. Lennon VA, Wingerchuk DM, Kryzer TJ, et al. A serum autoantibody marker of Neuromyelitis Optica: distinction from multiple sclerosis. Lancet 2004 364 : 2106 2112. (Pubitemid 39626806)
10. Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR. IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med 2005 202 : 473 477.
11. Amiry-Moghaddam M, Ottersen OP. The molecular basis of water transport in the brain. Nat Rev Neurosci 2003 4 : 991 1001. (Pubitemid 37486675)
12. Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG. Revised diagnostic criteria for Neuromyelitis Optica. Neurology 2006 66 : 1485 1489.
13. Warabi Y, Yagi K, Hayashi H, Matsumoto Y. Characterization of the T cell receptor repertoire in the Japanese Neuromyelitis Optica: T cell activity is up-regulated compared to multiple sclerosis. J Neurol Sci 2006 249 : 145 152. (Pubitemid 44665918)
14. Wu JS, Zhang MN, Carroll WM, Kermode AG. Characterisation of the spectrum of demyelinating disease in Western Australia. J Neurol Neurosurg Psychiatry 2008 79 : 1022 1026.
15. Rivera JF, Kurtzke JF, Booth VJ, Corona VT V. Characteristics of Devic's disease (Neuromyelitis Optica) in Mexico. J Neurol 2008 255 : 710 715.
16. Ghezzi A, Bergamaschi R, Martinelli V, et al. Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol 2004 251 : 47 52. (Pubitemid 38210489)
17. O'Riordan JI, Gallagher HL, Thompson AJ, et al. Clinical, CSF, and MRI findings in Devic's Neuromyelitis Optica. J Neurol Neurosurg Psychiatry 1996 60 : 382 387. (Pubitemid 26118744)
18. de Seze J, Lebrun C, Stojkovic T, Ferriby D, Chatel M, Vermersch P. Is Devic's Neuromyelitis Optica a separate disease? A comparative study with multiple sclerosis. Mult Scler 2003 9 : 521 525. (Pubitemid 37287734)
19. Kantarci OH, Weinshenker BG. Natural history of multiple sclerosis. Neurol Clin 2005 23 : 17 38.
20. Wingerchuk DM. Neuromyelitis Optica. Int MS J 2006 13 : 42 50. (Pubitemid 43764527)
21. Hummers LK, Krishnan C, Casciola-Rosen L, et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004 62 : 147 149. (Pubitemid 38082893)
22. Pittock SJ, Weinshenker BG, Lucchinetti CF, Wingerchuk DM, Corboy JR, Lennon VA, et al. Neuromyelitis Optica brain lesions localized at sites of high Aquaporin 4 expression. Arch Neurol 2006 63 : 964 968.
23. Adoni T, Lino AM, Marchiori PE, Kok F, Callegaro D. Seroprevalence of NMO-IgG antibody in Brazilian patients with Neuromyelitis Optica. Arq Neuropsiquiatr 2008 66 : 295 297. (Pubitemid 352030269)
24. Nakashima I, Fujihara K, Miyazawa I, et al. Clinical and MRI features of Japanese MS patients with NMO-IgG. J Neurol Neurosurg Psychiatry 2006 77 : 1073 1075.
25. Mandler RN, Ahmed W, Dencoff JE. Devic's Neuromyelitis Optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998 51 : 1219 1220. (Pubitemid 28473439)
26. Weinstock-Guttman B, Ramanathan M, Lincoff N, et al. Study of mitoxantrone for the treatment of recurrent Neuromyelitis Optica (Devic disease). Arch Neurol 2006 63 : 957 963. (Pubitemid 44036296)
27. Bakker J, Metz L. Devic's Neuromyelitis Optica treated with intravenous gamma globulin (IVIG). Can J Neurol Sci 2004 31 : 265 267. (Pubitemid 38724824)
28. Cree BA, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in Neuromyelitis Optica. Neurology 2005 64 : 1270 1272. (Pubitemid 40490534)
29. Jarius S, Aboul-Enein F, Waters P, et al. Antibody to aquaporin-4 in the long-term course of Neuromyelitis Optica. Brain 2008 131 : 3072 3080. (Pubitemid 351516748)
30. Kira J. Neuromyelitis Optica and Asian phenotype of multiple sclerosis. Ann N Y Acad Sci 2008 1142 : 58 71.